1
2
3

Wuxi Beta establishes partnership with American CIL

Release time:

2018-07-18

On July 18, 2018, Wuxi Beta Pharmaceutical Technology Co., Ltd. signed a supply agreement with CambridgeIsotopeLaboratories,Inc.(CIL) to jointly develop the industrialization of isotope labeled products such as urea-13C and promote the popularization of gastric Helicobacter pylori detection in China.

On July 18, 2018, Wuxi Beta Pharmaceutical Technology Co., Ltd. signed a supply agreement with Cambridge Isotope Laboratories, Inc. (CIL) to cooperate in the development of the industrialization of isotope labeled products such as urea-13C, and promote the detection of Helicobacter pylori in the stomach in China Popularity.

Previous

Wuxi Beta and Shenyang Research Institute of Chemical Industry to establish a cooperative relationship

Wuxi Beta establishes cooperative relationship with China Academy of Engineering Physics

Next

Previous

Wuxi Beta and Shenyang Research Institute of Chemical Industry to establish a cooperative relationship

Next

Wuxi Beta establishes cooperative relationship with China Academy of Engineering Physics